Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Integra Lifesciences ( (IART) ) just unveiled an announcement.
Integra LifeSciences has adopted a change in control severance program effective January 1, 2025, providing severance and benefits to certain executives in the event of employment termination following a company change in control by December 31, 2025. The program aims to ensure stability and incentivize retention during potential transitions, impacting executive compensation and company operations if a change occurs.
More about Integra Lifesciences
Integra LifeSciences Holdings Corporation operates in the medical technology industry, specializing in products and services for tissue technologies and surgical specialties.
YTD Price Performance: -45.56%
Average Trading Volume: 883,830
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.83B
See more data about IART stock on TipRanks’ Stock Analysis page.
Trending Articles
- Sezzle (NASDAQ:SEZL) Plummets as Hindenburg Report Crashes Into It
- Ford’s (NYSE:F) EV Worries Mount in Europe
- Intel’s (NASDAQ:INTC) New Battlemage GPU is a Winner
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
